Sponsored by: GE Healthcare

MRI: Page 126

The unreasonable radiologist
By Dr. Paul McCoubrie
We should be bold and decisive, borderline unreasonable, writes Dr. Paul McCoubrie. We need to all become a little more "Dr. No," and we need the wisdom to distinguish clinical demand from clinical need, he notes.
March 6, 2018
2018 03 06 18 35 5605 Paul Mc Coubrie 400
Focus on FOCUS, a new DWI-MRI protocol for breast lesions
By Rebekah Moan
A new type of diffusion-weighted imaging (DWI) is giving conventional breast MRI a run for its money. Field-of-view optimized and constrained undistorted single-shot (FOCUS) imaging can identify 85% of suspicious breast lesions, ECR 2018 delegates learned in Vienna.
March 4, 2018
2016 10 05 17 45 45 493 Breast Cancer 400
New treatment strategies give hope to patients with MSK tumors
By Katharina Miedzinska
In today's Special Focus Session, experts provided an update on imaging modalities, treatment strategies, and therapy monitoring in patients with musculoskeletal (MSK) tumors, aiming to raise awareness of how multimodality imaging can influence therapeutic balancing between tumor control and quality of life.
March 3, 2018
2018 03 03 19 11 3915 2018 03 04 Msk Tumors1 20180303193440
Guerbet presents contrast management software at ECR
By AuntMinnieEurope.com staff writers
French contrast developer Guerbet is featuring its new Contrast&Care contrast media management software at ECR 2018 in Vienna.
March 3, 2018
ESNR survey taps into future of imaging for dementia
By Wayne Forrest
VIENNA - While there is considerable consensus on which modalities and protocols to use to diagnose dementia, few neuroradiologists feel comfortable using advanced imaging, structured reports, or visual rating scales, according to survey results from the European Society of Neuroradiology (ESNR) presented on Saturday at ECR 2018.
March 3, 2018
2018 02 28 18 53 9645 Ecr 2018 400
Musculoskeletal speakers reveal trade secrets on sports injuries
By Becky McCall
To achieve success and consistently good results in sports imaging, you must be descriptive in the radiology report, know what pitfalls to avoid, and find out what is important to the surgeon. That's the view of Dr. Theodore Miller, from Weill Cornell Medicine of Cornell University in New York City and a speaker at today's transatlantic master class on sports injuries.
March 2, 2018
2018 03 03 00 06 1077 2018 03 03 Sport Mri 20180303001846
Evidence-based medicine 'misused' in breast MRI
By Rebekah Moan
VIENNA - During a refresher course at ECR 2018, breast MRI expert Dr. Christiane Kuhl said the principles of evidence-based medicine have been misused in the case of preoperative breast MRI, and that's part of the reason why the modality hasn't been adopted more widely by the surgical community.
March 2, 2018
2016 11 16 11 11 54 211 2016 11 16 Kuhl Thumb
Leave no invasive breast cancer behind by using MRI
By Rebekah Moan
VIENNA - Mammography and ultrasound underestimate 30% of disease in patients with invasive ductal carcinoma, according to research from Israel presented at ECR 2018. MRI overestimates the extent of disease, but at least no cancer is left behind.
March 2, 2018
2018 02 28 18 53 9645 Ecr 2018 400
Video from ECR 2018: Thomas Beyer on hybrid imaging
VIENNA - The successful clinical implementation of hybrid imaging in Europe still appears to be a long way off. Major challenges remain, particularly in terms of training and education and also the availability of equipment. Thomas Beyer, PhD, MBA, professor of physics of medical imaging at the Medical University of Vienna, speaks about an extensive new survey that sheds light on the issues to be resolved.
March 2, 2018
2018 03 03 11 49 7594 Beyer Thomas Ecr 2018 Video 400
Necessity of gadolinium contrast comes under scrutiny
By Katrina Megget
Gadolinium-enhanced MRI scans have been the gold standard in suspected cases of vestibular schwannoma and multiple sclerosis (MS), but given the growing evidence of deposits left in the brain, debate has ensued about how to image wisely. Is it always necessary to use gadolinium contrast agents? Regarding vestibular schwannoma and MS, today's Pros and Cons Session will explore this question.
March 1, 2018
2018 03 02 06 07 8916 2018 03 02 Gadolinium2 20180302062418
MRI holds promise for immunotherapy but needs more research
By Mélisande Rouger
Immunotherapy is a booming field, and recent trials have shed light on the effects of these drugs on cancer. A panel of experts will unveil the latest results and discuss the challenges for imaging in triaging patients and assessing treatment response during the dedicated New Horizons session today at ECR.
March 1, 2018
2018 03 02 05 05 0339 2018 03 02 Immunotherapy 20180302055502
Facebook Live from ECR 2018: Day 3
Our coverage of ECR 2018 continues with a discussion of vendor activity in the technical exhibits, as well as a review of recent research on gadolinium retention from MRI contrast. Appearing as a guest on today's broadcast is Wayne Forrest, features editor of AuntMinnie.com.
March 1, 2018
2018 03 06 22 48 9700 2018 02 28 Facebook Live3b Thumb
Previous Page
Page 126 of 266
Next Page